Wells Fargo Maintains Overweight on Scotts Miracle Gro, Lowers Price Target to $60
Benzinga Newsdesk 4 weeks ago
Analyst RatingsNewsPrice Target
Wells Fargo analyst Chris Carey maintains Scotts Miracle Gro (NYSE:SMG) with a Overweight and lowers the price target from $77 to $60.
Wells Fargo analyst Chris Carey maintains Scotts Miracle Gro (NYSE:SMG) with a Overweight and lowers the price target from $77 to $60.